BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20021712)

  • 21. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.
    Kedem-Dickman A; Maman E; Yung Y; Yerushalmi GM; Hemi R; Hanochi M; Dor J; Hourvitz A
    Reprod Biomed Online; 2012 May; 24(5):540-6. PubMed ID: 22421733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endocrine milieu in naturally matured follicles is different in women with high serum anti-Müllerian hormone concentrations.
    von Wolff M; Mitter VR; Jamir N; Stute P; Eisenhut M; Bersinger NA
    Reprod Biomed Online; 2021 Aug; 43(2):329-337. PubMed ID: 34176772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of follicular fluid and serum anti-Mullerian hormone levels as predictors of the outcome of assisted reproductive treatment.
    Hattori Y; Sato T; Okada H; Saito C; Sugiura-Ogasawara M
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):252-6. PubMed ID: 23622971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of anti-mullerian hormone on stem cell factor in serum, follicular fluid and ovarian granular cells of polycystic ovarian syndrome patients.
    Zhang JF; Yu CM; Yan LL; Ma JL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7877-7882. PubMed ID: 30536333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular fluid anti-Müllerian hormone: a predictive marker of fertilization capacity of MII oocytes.
    Tramišak Milaković T; Panić Horvat L; Čavlović K; Smiljan Severinski N; Vlašić H; Vlastelić I; Ljiljak D; Radojčić Badovinac A
    Arch Gynecol Obstet; 2015 Mar; 291(3):681-7. PubMed ID: 25205183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction.
    Berker B; Kaya C; Aytac R; Satiroglu H
    Hum Reprod; 2009 Sep; 24(9):2293-302. PubMed ID: 19443458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization.
    Takahashi C; Fujito A; Kazuka M; Sugiyama R; Ito H; Isaka K
    Fertil Steril; 2008 Mar; 89(3):586-91. PubMed ID: 17543956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Müllerian hormone in women with polycystic ovary syndrome.
    Pehlivanov BK; Orbetzova MM
    Folia Med (Plovdiv); 2011; 53(1):5-10. PubMed ID: 21644399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and follicular fluid testosterone concentrations do not correlate, questioning the impact of androgen supplementation on the follicular endocrine milieu.
    von Wolff M; Stute P; Eisenhut M; Marti U; Bitterlich N; Bersinger NA
    Reprod Biomed Online; 2017 Nov; 35(5):616-623. PubMed ID: 28821386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
    La Marca A; Sighinolfi G; Radi D; Argento C; Baraldi E; Artenisio AC; Stabile G; Volpe A
    Hum Reprod Update; 2010; 16(2):113-30. PubMed ID: 19793843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Müllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development.
    O'Brien Y; Wingfield M; O'Shea LC
    Reprod Biol Endocrinol; 2019 Jun; 17(1):47. PubMed ID: 31217014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimüllerian hormone levels and IVF outcomes in polycystic ovary syndrome women: a scoping review.
    Delamuta LC; Fassolas G; Dias JA; Henrique LFO; Izzo FPM; Izzo CR
    JBRA Assist Reprod; 2024 Jun; 28(2):299-305. PubMed ID: 38446747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.
    Fallat ME; Siow Y; Marra M; Cook C; Carrillo A
    Fertil Steril; 1997 May; 67(5):962-5. PubMed ID: 9130910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive value of serum concentrations of anti-Müllerian hormone for oocyte quality, fertilization, and implantation.
    Borges E; Braga DPAF; Setti A; Figueira RC; Iaconelli A
    JBRA Assist Reprod; 2017 Sep; 21(3):176-182. PubMed ID: 28837024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes.
    Liu XH; Wu XH; Yang S
    Arch Gynecol Obstet; 2019 Dec; 300(6):1773-1783. PubMed ID: 31631249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.
    Tal R; Seifer DB; Grazi RV; Malter HE
    Reprod Biol Endocrinol; 2014 Aug; 12():82. PubMed ID: 25141961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.